Nivolumab in patients with relapsed or refractory Hodgkin lymphoma - Preliminary safety, efficacy and biomarker results of a phase I study Meeting Abstract
| Authors: | Armand, P.; Ansell, S. M.; Lesokhin, A. M.; Halwani, A.; Millenson, M. M.; Schuster, S. J.; Timmerman, J.; Borrello, I.; Gutierrez, M.; Scott, E. C.; Cattry, D.; Chapuy, B.; Ligon, A. H.; Rodig, S. J.; Zhu, L. L.; Grosso, J. F.; Kim, S. Y.; Shipp, M. A. |
| Abstract Title: | Nivolumab in patients with relapsed or refractory Hodgkin lymphoma - Preliminary safety, efficacy and biomarker results of a phase I study |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349233805057 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.289.289 |
| Notes: | Meeting Abstract: 289 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
